Objective-Monocyte-derived foam cells are one of the key players in the formation of atherosclerotic plaques. Adenosine receptors and extracellular adenosine have been demonstrated to modulate foam cell formation. ADK (adenosine kinase) is a major enzyme regulating intracellular adenosine levels, but its functional role in myeloid cells remains poorly understood. To enhance intracellular adenosine levels in myeloid cells, ADK was selectively deleted in novel transgenic mice using Cre-LoxP technology, and foam cell formation and the development of atherosclerotic lesions were determined. Approach and Results-ADK was upregulated in macrophages on ox-LDL (oxidized low-density lipoprotein) treatment in vitro and was highly expressed in foam cells in atherosclerotic plaques. Atherosclerotic mice deficient in ADK in myeloid cells were generated by breeding floxed ADK (ADK 
A therosclerosis is a chronic inflammatory vascular disease that encompasses the continuum from an early fatty streak, established lesion, vulnerable plaque to ruptured plaque. [1] [2] [3] In response to vascular injury induced by disturb flow, lipid accumulation, and many other risk factors, circulating monocytes are recruited to the arterial vessel wall, differentiate into macrophages, and further turn into foam cells after phagocytosis of modified lipids. [1] [2] [3] Accumulation of foam cells in the subendothelial space leads to fatty streak formation, which is a critical stage in the initiation of atherosclerosis. [4] [5] [6] These changes do not go unopposed, and macrophages and vascular cells also activate a variety of pathways to reduce macrophage lipid loading and suppress foam cell formation. For example, macrophages and vascular cells produce adenosine-an endogenous purine ribonucleoside that binds to and activates the A2AR (adenosine receptor 2A) on foam cells and consequently diminishes foam cell formation. 7, 8 This concept is in line with the many beneficial effects of adenosine in a number of vascular disorders. Previous studies on the effect of adenosine on foam cell formation have emphasized the effect of extracellular adenosine. 7, 8 However, adenosine is also generated intracellularly, 9 and the role of intracellular adenosine in regulating foam cell formation has not yet been appreciated.
The generation of intracellular adenosine occurs from either the dephosphorylation of AMP by 5′-nucleotidase (>70%) or the hydrolysis of S-adenosyl-homocysteine via S-adenosyl homocysteine hydrolase (SAHH; Figure IVA in the onlineonly Data Supplement). 9, 10 In addition, intracellular ADK (adenosine kinase) and ADA (adenosine deaminase) are the enzymes responsible for the clearance of intracellular adenosine. 9, 10 Given that the Km of ADK for adenosine (1 µmol/L) is much lower than that of ADA (25-150 µmol/L), ADK is regarded as the major enzyme regulating the levels of intracellular adenosine under both physiological and pathophysiological conditions 9, 10 ( Figure IVA in the online-only Data Supplement). Blockade of ADK disrupts the balance of adenosine nucleotides and significantly enhances the intracellular adenosine concentration. 11 Elevated intracellular adenosine reverses SAHH-mediated hydrolysis and directs the reaction toward the formation of S-adenosyl homocysteine, which is a potent end product inhibitor of transmethylation reactions 12, 13 ( Figure IVA in the online-only Data Supplement). Inhibition of the transmethylation pathway by SAHH inhibitors results in a reduction of immune or inflammatory responses in T cells and macrophages. 14, 15 It remains unclear whether increased intracellular adenosine by ADK deletion in macrophages modulates foam cell formation by altering flux through the transmethylation pathway.
In the current study, we have utilized multiple approaches, including in vitro assays with ADK-deficient bone marrowderived macrophages (BMDMs), foam cell formation, as well as experiments in vivo in models of atherosclerosis in mice selectively deficient in ADK in myeloid cells to determine the role of myeloid ADK in regulating foam cell formation and the formation of atherosclerotic lesions in mice deficient in apolipoprotein E.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Mouse Generation and Breeding
ADK floxed (ADK F/F ) mice were generated by insertion of loxP sites on both sides of exon 7 of the ADK gene. ADK F/F mice were then crossed with Lysm-cre (myeloid-specific Cre recombinase expressing) mice-a mouse line in which Cre is selectively expressed in lysozymeexpressing myeloid cells (stock No. 004718; The Jackson Laboratory, Bar Harbor, ME 
Animal Experiments
For the atherosclerosis studies, we used genetically engineered male and female mice based on established protocols with a minor modification. 16 WT mice at 7 weeks of age were fed a Western diet for 8 weeks. The aortic sinuses and brachiocephalic arteries were collected and processed for analysis of lesion size and changes in cellularity. Flow cytometry analysis of inflammatory cells in atherosclerotic lesions was conducted according to published protocols. 18 Detailed Materials And Methods are available in the online-only Data Supplement.
BMDM Culture and Treatments
After euthanization of mice, femurs and tibias were collected and transected. Bone marrow cells were flushed from the femurs and tibias. The cell suspension was pipetted repeatedly to obtain a singlecell suspension, which was then filtered with a 70-μm cell strainer and centrifuged at 800g for 8 minutes. The acquired cells were plated at a density of 2×10 6 /mL and cultured in RPMI (Roswell Park Memorial Institute) 1640 medium (SH30809.01B; HyClone, Logan, UT) supplemented with 10% FBS (04-002-1A; Biological Industries, Beit Haemek, Israel), 15% L929-conditioned medium, and 1% penicillin-streptomycin for 6 days. In some experiments, 50 or 100 μg/mL ox-LDL (oxidized low-density lipoprotein; YB-002; Yiyuan Biotech, Guangzhou, Guangdong, China), 20 μM ABT702 (2372; Tocris Bioscience, Bristol, United Kingdom), 5 μM ZM241385 (1036; Tocris Bioscience, Bristol, United Kingdom), 2 μM MRS1754 (2752; Tocris Bioscience, Bristol, United Kingdom), 2 μM 5-Aza-2′-deoxycytidine (5′-Aza-dc; A3656; Sigma-Aldrich, Saint Louis, MO), or 20 μM adenosine periodate oxidized (A7154; Sigma-Aldrich, Saint Louis, MO) was added to the culture medium to treat macrophages.
Quantification of Atherosclerotic Lesions
Aortas were fixed with 4% PFA (as described above) and rinsed in distilled water (30 seconds) and 60% isopropyl alcohol (15 seconds) successively. The aortas were stained with Oil Red O (O0625; SigmaAldrich, Saint Louis, MO) staining buffer for 30 minutes, rinsed in 60% isopropyl alcohol for 20 seconds to remove background staining, and then placed in PBS to remove the remaining adventitial tissue. Aortas were pinned and the interior exposed for photography. 
Measurement of Total Cholesterol Level in Foam Cells
After ox-LDL treatment, the total cholesterol in foam cells was extracted using hexane:isopropanol (3:2) and assayed by Amplex Red Cholesterol Assay Kit (A12216; Invitrogen, Eugene, OR). The fluorescence was measured in a fluorescence microplate reader using excitation at 560 nm and emission detection at 590 nm. The cholesterol content was adjusted to the protein concentration (μg/mg).
Dil-ox-LDL Uptake
BMDMs were incubated with Dil-ox-LDL (YB-0010; Yiyuan Biotech, Guangzhou, Guangdong, China) for 6 hours. For confocal microscopy, the cells cultured in Chamber Slide System (154534PK; Nunc Lab-Tek II, Roskilde, Denmark) were fixed with 4% PFA and mounted with antifade mountant with DAPI (4',6-diamidino-2-phenylindole; S36938; Life Technologies, Eugene, OR) and then fixed with nail polish. For flow cytometry analysis, the cells were trypsinized, washed with PBS, and resuspended in 500 μL PBS for flow cytometry analysis.
Cholesterol Efflux Assay
BMDMs were first incubated with 300 μL BODIPY cholesterol (810255P; Avanti Polar Lipids, Alabaster, AL) labeling medium for 1 hour. After washing 3 times with PBS, the cells were equilibrated with RPMI 1640-containing 0.2% BSA for 12 hours. The fluorescence in the cells at this time point was regarded as the total fluorescence. The cells were then incubated with 25 µg/mL human plasma apoA-I (apolipoprotein A-1; SRP4693; Sigma-Aldrich, Saint Louis, MO) or 50 µg/mL native human HDL (high-density lipoprotein; YB-003; Yiyuan Biotech, Guangzhou, Guangdong, China) for 12 hours. After incubation, the efflux medium was collected and centrifuged at 10 000g, 4°C for 5 minutes, and the fluorescence intensity was measured (excitation, 482 nm; emission, 515 nm). The percentage of cholesterol efflux was calculated by dividing the fluorescence in the medium by the total fluorescence.
Methylation-Specific Polymerase Chain Reaction
Genomic DNA was extracted from mouse BMDM using the DNAiso reagent (9770Q; Takara, Kusatsu, Shiga, Japan). A Bisulfite Conversion Reaction (DP215; TIANGEN, Beijing, China) was then conducted to convert unmethylated C to U, whereas methylated C remains unchanged. Bisulfite-treated DNA was then used as a template for methylation-specific polymerase chain reaction (PCR) according to the manufacturer's instructions (R100A; Takara, Kusatsu, Shiga, Japan). The MS-qPCR (methylation-specific quantitative polymerase chain reaction) primers (M primer, U primer) were designed using MethPrimer 2.0 using a template 10 00 bp upstream and downstream of the mouse ABCG1 (ATP-binding cassette transporter G1) transcription start site.
Bisulfite Sequencing PCR
Genomic DNA was extracted from mouse BMDM and modified using the the EpiTect Fast DNA Bisulfite Kit (59824; QIAGEN, Dusseldorf, German). CpG (cytosine-phosphate-guanine) islands in the ABCG1 promoter and ABCA1 (ATP-binding cassette transporter A1) promotor were amplified. The amplified PCR products were cloned into a linearized vector using T4 DNA ligase (EL0014;
Invitrogen, Carlsbad, CA). Ten positive clones were picked for DNA sequencing analysis. The level of methylated CpG sites between −96 and +188 bp on the ABCG1 promotor was compared using genomic DNA from ADK KO 
Statistical Analysis
Statistical analyses were performed with GraphPad Software. Data are presented as the mean±SEM. Normal distribution and equality of variances of all data was evaluated using the Kolmogorov-Smirnov test and F test. Data that followed a normal distribution were analyzed by 1-way ANOVA with Bonferroni post hoc tests or by 2-tailed unpaired Student t test. Data that failed normal distribution were analyzed by Kruskal-Wallis test with post hoc tests or by nonparametric Mann-Whitney U test. The null hypothesis was rejected at P <0.05.
Results

Increased ADK Expression in Foam Cells
To determine the expression level of ADK in atherosclerotic arteries, we examined arteries of WT (wild type) mice and ApoE −/− mice. Immunohistochemical staining of ADK showed that expression levels in atherosclerotic arteries were much higher than that in arteries from WT mice ( Figure 1A ). Furthermore, immunofluorescent double staining with Mac-2 (macrophage surface antigen-2) and ADK antibodies showed that in sections from atherosclerotic arteries, cells in Mac-2-positive areas were ADK positive ( Figure 1B ), indicating that indeed macrophages/foam cells express ADK.
To examine ADK expression in in vitro-induced foam cells, BMDMs were cultured and then challenged with ox-LDL. As shown in Figure 1C , the mRNA levels of ADK were not changed after ox-LDL treatment. However, the protein levels of ADK were increased in a time-dependent manner ( Figure 1D ), and this was accompanied by decreased levels of intracellular adenosine ( Figure 1E ).
Reduced Atherosclerosis in Mice Deficient in Myeloid ADK
To determine whether macrophage ADK deficiency affects atherosclerosis development, ApoE WT mice were fed a Western diet for 16 weeks to induce atherogenesis. These mice exhibited no significant differences in the levels of blood cholesterol and triglycerides, the number of circulating leukocytes and their differentials (Tables I and II in the online-only Data Supplement), whereas it was noted that female mice showed a modest decrease in blood glucose in ApoE 
Decreased Foam Cell Formation of ADK-Deficient Macrophages
Foam cell formation plays a vital role in the development of atherosclerotic lesions. [4] [5] [6] For this reason, we investigated whether ADK deficiency impacts foam cell formation. Bone marrow cells from ADK WT and ADK MAC-KO mice were cultured and then differentiated into BMDMs, followed by treatment with ox-LDL for 24 hours to induce foam cell formation. Oil Red O staining ( Figure 3A and 3B) revealed that ADK deficiency decreased foam cell formation by about 40% as compared with the control group, and total cholesterol levels were much lower in ADK-deficient foam cells than in WT foam cells ( Figure 3C ). BMDMs from WT mice were pretreated with vehicle or the ADK inhibitor ABT702 and then incubated with ox-LDL for 24 hours to induce foam cell formation. Oil Red O staining ( Figure 3D and 3E) and total cholesterol measurements ( Figure 3F ) also demonstrated that inhibition of ADK activity decreases foam cell formation. These results indicate that inactivation of ADK impairs the ability of ox-LDL to promote foam cell formation-a critical process in atherosclerosis.
ADK deficiency increases both intracellular and extracellular adenosine levels in endothelial cells. 19 We found that loss of ADK elicited similar effects in BMDMs ( Figure 4A and  4B ). In addition, we also found that ADK deficiency decreased both intracellular and extracellular ATP/ADP per AMP levels in BMDMs ( Figure IVB and IVC in the online-only Data Supplement). To determine whether adenosine reduces foam cell formation via activation of adenosine receptors, we next treated macrophages with the A2AR antagonist ZM241385, the A 2B R antagonist MRS1754, or both in the presence of the ADK inhibitor ABT702, followed by incubation with ox-LDL for 24 hours. Treatment of BMDMs with adenosine receptor antagonists did not affect ox-LDL-induced foam cell formation in ABT702-treated macrophages ( Figure 4D ), which indicates that decreased formation of foam cells in ADK-deficient macrophages is adenosine receptor independent. 
Augmented Cholesterol Efflux in ADK-Deficient Foam Cells
Foam cell formation involves a balance between uptake of modified LDL and efflux of cholesterol in macrophages. 5 Therefore, decreased foam cell formation in ADK-deficient macrophages may result from compromised ox-LDL uptake or enhanced cholesterol efflux or both. To distinguish between these possibilities, we first compared ox-LDL uptake in macrophages of ADK WT and ADK MAC-KO mice using confocal microscopy and fluorescence-activated cell sorter analysis. BMDMs of ADK WT and ADK MAC-KO mice were incubated with fluorescent Dil-ox-LDL for 6 hours. There was no significant difference in ox-LDL uptake between macrophages of ADK WT and ADK MAC-KO mice ( Figure 5A and 5B). Cholesterol efflux was determined using BODIPY cholesterol 20 -a fluorescent analog of free cholesterol. Cholesterol efflux to mature HDL was enhanced by 36% in the group of ADK-deficient foam cells compared with the control group ( Figure 5D) . No difference in efflux to nascent apoA-I was found between the 2 groups ( Figure 5C ). Thus, enhanced cholesterol efflux to mature HDL contributes to decreased foam cell formation for ADK-deficient macrophages.
To investigate the molecular mechanisms underlying decreased foam cell formation, we next determined whether ADK deficiency alters the expression of SR-A (scavenger receptor A) and CD36 or the cholesterol transporters, ABCA1 and ABCG1. No difference was found in the mRNA levels of ABCA1, SR-A, and CD36 between the 2 groups ( Figure 5E ). However, the mRNA level of cholesterol transporter ABCG1 was increased by 1.5-fold in ADK-deficient macrophages as compared with WT macrophages ( Figure 5E ). We then examined the protein expression of ABCG1 in macrophages from ADK WT and ADK MAC-KO mice by immunoblotting. The protein level of ABCG1 was increased by 2.6-fold in ADK-deficient macrophages as compared with control macrophages ( Figure 5F ). Furthermore, we also examined the effect of ADK deficiency on ABCG1 expression in the presence of ox-LDL. The level of ABCG1 in ADK-deficient macrophages was much higher than that of WT macrophages after ox-LDL treatment ( Figure 5G ). We also found that the protein level of ABCG1 was increased about 1.9-fold in the aortic lesions of ApoE Figure 5H ). Moreover, using a published protocol, 21 we used flow cytometry to isolate macrophages from atherosclerotic plaques ( Figure V D, E, F, and H) , 1-way ANOVA with Bonferroni post hoc tests (for G), and Mann-Whitney U test (for I).
sinuses using both mac-2 and ABCG1 antibodies showed that ABCG1 protein expression was also significantly upregulated in plaque macrophages of ApoE −/− /ADK MAC-KO mice versus that in ApoE −/− /ADK WT mice ( Figure 5J ). These results suggest that ADK deficiency enhances cholesterol efflux in macrophages through ABCG1 but not ABCA1.
Decreased DNA Methylation of ABCG1 in ADK-Deficient Macrophages
In neurons and endothelial cells, ADK deficiency enhances the levels of intracellular adenosine and S-adenosyl homocysteine. 13, 19 We found that this also occurs in ADK-deficient BMDMs ( Figure 4C ). To test whether intracellular adenosine regulates ABCG1 expression via extracellular adenosine receptors after adenosine is transported out, ADK-deficient BMDMs were treated with the A2AR antagonist ZM241385 and the A 2B R antagonist MRS1754. Neither treatment altered the increased expression level of ABCG1 in ADK-deficient macrophages ( Figure 6A ). Elevated intracellular adenosine levels have been shown to reduce DNA methylation through inhibition of SAHH activity. 13, 19 To test whether decreased SAHH activity and subsequent inhibition of DNA methylation are associated with the increased expression of ABCG1 in ADKdeficient macrophages, we treated BMDMs with the SAHH inhibitor, adenosine periodate oxidized or DNA methylation inhibitor, 5′-Aza-dc. As shown in Figure 6B -6D, adenosine periodate oxidized upregulated ABCG1 at the protein level, and 5′-Aza-dc increased the level of ABCG1 at both the mRNA and protein levels, suggesting that suppression of DNA methylation enhances ABCG1 expression in ADK-deficient macrophages. To assess changes in the methylation level of the ABCG1 gene, DNA from ADK-deficient and WT BMDMs was modified by bisulfite, and the levels of promoter methylation were quantified by RT-PCR. The level of methylated ABCG1 was much lower in ADK-deficient BMDMs than in the WT macrophages ( Figure 6E) . Furthermore, the level of methylated ABCG1 was also much lower in sorted macrophages from plaques of ApoE −/− /ADK MAC-KO mice than that from ApoE −/− /ADK WT mice ( Figure 6F ). To provide additional validation of the PCR data, bisulfite sequencing of ABCG1 CpG islands was performed ( Figure 6G ). The fragment between −96 and +188 bp of the ABCG1 promoter region was evaluated. The methylation rate of CpG elements in ADK-deficient BMDMs was reduced by 68% compared with that in control macrophages ( Figure 6H ). These results indicate that decreased DNA methylation in the ABCG1 promoter is at least one of the major factors underlying increased ABCG1 expression in ADK-deficient macrophages.
Discussion
In this study, we found that augmentation of intracellular adenosine levels through deletion or inhibition of ADK suppresses foam cell formation and subsequently inhibits atherosclerosis. Interestingly, we found that these effects are largely independent of purinergic receptor activation and instead occur through decreased DNA methylation of the ABCG1 gene leading to increased protein expression. These findings reveal a novel epigenetic pathway by which intracellular adenosine exerts antiatherogenic effects in macrophages.
ADK regulates intracellular adenosine production in foam cells, which are a major cellular component of atherosclerotic lesions. [4] [5] [6] The cores of atherosclerotic lesions are hypoxic, as evidenced by the increased levels of HIFs (hypoxia-induced factors) and positive pimonidazole staining. [22] [23] [24] Pathways for adenosine accumulation are highly active under hypoxic conditions and subject to transcriptional regulation by HIFs. 25, 26 For example, the major adenosinegenerating enzymes, such as CD73 and 5′-nucleotidase, and adenosine-catabolizing enzymes, such as ADK and ADA, are regulated by HIFs. 25, 26 These changes presumably augment adenosine levels resulting in stimulation of adenosine receptors, which are thought to mediate the beneficial effect of adenosine. Indeed, a few studies have demonstrated that adenosine and adenosine receptors are important for suppression of foam cell formation. 8 ADK is an intracellular enzyme that metabolizes intracellular adenosine and subsequently limits the export of adenosine into the extracellular environment. 9 We have shown that in response to hypoxia, endothelial ADK is downregulated, resulting in an increase of both intracellular and extracellular adenosine. The enhancement of adenosine levels in endothelial cells accelerates angiogenesis. 19 In contrast, in macrophages treated with ox-LDL, ADK expression is increased, and this is accompanied by a decrease in intracellular adenosine. Increased ADK levels in foam cells may decrease the overall level of adenosine in lesions and, therefore, oppose the beneficial effects of adenosine, indicating the necessity of inhibiting ADK to suppress foam cell formation.
We found that ADK deficiency in macrophages led to a reduction in ABCG1 gene methylation and reduced foam cell formation. Foam cell formation is the net result of lipid uptake versus efflux with each pathway subject to regulatory control by a range of molecules. [4] [5] [6] It is well established that ABCA1 and ABCG1 are major regulators of lipid efflux. 27 ABCG1 expression is subject to epigenetic control, and its expression level is inversely correlated with the level of gene methylation. 28, 29 Clinical data show that the rates of diabetes mellitus and cardiovascular disorders are increased in patients with high levels of ABCG1 methylation. [30] [31] [32] We have found that ABCG1-mediated cholesterol efflux plays an important role in decreased foam cell formation in ADK-deficient macrophages. In ADK-deficient macrophages, ABCG1 protein expression was not affected by antagonists of adenosine receptors suggesting other actions of adenosine. In contrast, the increased ABCG1 level in ADK-deficient macrophages is seen in macrophages treated with DNA methylation inhibitor. In endothelial cells, ADK deficiency leads to DNA hypomethylation. 19 In line with a previous study, both bisulfite sequencing and methylationspecific PCR of ABCG1 revealed a significant decrease in the levels of DNA methylation on the ABCG1 gene promoter in ADK-deficient macrophages. In contrast, no significant decrease in the levels of DNA methylation on the ABCA1 gene promotor was found in ADK-deficient macrophages ( Figure transport proteins cholesterol 27-hydroxylase and ABCA1, both of which are important for transport of cholesterol out of macrophages, resulting in decreased foam cell formation. 33, 34 Second, LOX-1 (lectin-like oxidized LDL receptor-1) is a membranebound receptor that is found at high concentration in human atherosclerotic lesions and cultured human macrophages. 35, 36 As a cell surface endocytosis receptor, macrophage LOX-1 binds and internalizes ox-LDL and, therefore, promotes foam cell formation. A2AR activation downregulates macrophage LOX-1 and inhibits foam cell formation. 8 In contrast to the above studies, blocking adenosine receptors, including A2AR and A2BR, did not reverse decreased foam cell formation in ADK-deficient macrophages, indicating that the ability of ADK deficiency to regulate foam cell formation does not occur through adenosine receptors. ADK deletion increases intracellular adenosine levels and conceptually is thought to be transported to the extracellular compartment to activate adenosine receptors. 9, 19 It is likely that adenosine receptor occupancy secondary to increased extracellular adenosine may repress foam cell formation under different conditions. However, in macrophages with ADK deficiency, the intracellular epigenetic pathway seems to be the dominant effect. Under these conditions, the effect of adenosine receptors on antifoam cell formation in ADK-deficient macrophages may not be as easily detected.
The ability of ADK deficiency to mitigate macrophage inflammation may also contribute to attenuated atherosclerosis in ApoE −/− /ADK MAC-KO mice. ADK deficiency did not significantly affect the percentages of circulating Ly6C hi and Ly6C lo monocyte, the levels of major monocyte recruiting molecules, such as PSGL-1 (P-selection glycoprotein ligand-1), L-selectin, CCR2 (C-C chemokine receptor type 2), and VLA-4 (very late antigen-4) ( Figure IC in the onlineonly Data Supplement), as well as M1/M2 macrophage polarization in in vitro assays. However, in response to lipopolysaccharide stimulation, ADK-deficient macrophages released lower levels of proinflammatory cytokines, such as TNFα (tumor necrosis factor-alpha), IL-6 (interleukin), and IL-1β (data not shown). The effect of adenosine receptor 2, especially A2AR, on cytokine production from activated macrophages has been shown to be complex. Whereas a large body of studies have reported that the occupancy of A2AR with either exogenous adenosine or A2AR agonists suppresses production of proinflammatory cytokines, 37 -41 a recent study shows that A2AR-deficient macrophages exhibit a low level of constitutive inflammasome activation. 42 Previous studies have indicated that macrophage ABCG1 is critically involved in the production of proinflammatory cytokines. 43, 44 Therefore, in ADK-deficient macrophages, the suppression of inflammatory activity may be attributed to upregulation of ABCG1. The post-translational methylation of lysine 4 of histone 3 is associated with the transcription of proinflammatory cytokines. 45, 46 In endothelial cells, ADK deficiency decreases the levels of methylated histone 3 on lysine 4 and further decreases endothelial inflammation. 47 It is likely that a similar signaling modulation also exists in macrophages and that the low level of methylated histone results in suppressed inflammation in ADK-deficient macrophages.
The importance of lymphocytes in atherosclerosis has been appreciated for decades and it has been demonstrated that regulatory T cells play a protective role in atherogenesis in mice with hyperlipidemia. [48] [49] [50] The percentage of blood regulatory T cells is elevated in myeloid ADK-deficient mice compared with controls. Additionally, a slight increase of regulatory T cells in atherosclerotic lesions in myeloid ADKdeficient mice was observed although the increase did not reach significance. Increased regulatory T cells in myeloidspecific ADK-deficient mice may also contribute to the decreased atherosclerosis observed in these mice, although it remains unclear and further study is needed to determine the mechanism by which the number of regulatory T cells is increased and establish cause and effect.
Collectively, we have demonstrated that ADK deletion in macrophages exerts an antiatherosclerotic effect by decreasing foam cell formation through epigenetic modulation of DNA methylation of ABCG1, which enhances ABCG1 expression leading to increased lipid efflux from foam cells. We have recently shown an anti-inflammatory effect of ADK deficiency on endothelial cells. 47 Therefore, targeting ADK, which can influence multiple cellular participants in the formation of atherosclerosis, is likely to be a promising target for the prevention and treatment of atherosclerosis.
